Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion effect on brain activation in smokers
NCT03920319Phase 1Completed
- Sponsor
- University of California, Los Angeles
- Start
- Jan 2004
- Primary completion
- Dec 2005
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in nicotine dependence comparing Bupropion with Placebo (2 arms). Primary endpoints: Craving ratings at 8 weeks and Regional brain activation in response to cigarette-related cues at 8 weeks. Started Jan 2004; status: completed.
02
Drugs
bupropion
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT03920319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03920319.